• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.9878498
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
222.38
67045.62
EPS(TTM)
Face Value()
Div & Yield %
1.85
5
0.12
 

poonawalla fincorp limited
Sharika Enterprises reports consolidated net loss of Rs 2.42 crore in the March 2026 quarter
May 21,2026
Net loss of Sharika Enterprises reported to Rs 2.42 crore in the quarter ended March 2026 as against net profit of Rs 5.03 crore during the previous quarter ended March 2025. Sales rose 20.89% to Rs 21.01 crore in the quarter ended March 2026 as against Rs 17.38 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 8.85 crore in the year ended March 2026 as against net loss of Rs 0.23 crore during the previous year ended March 2025. Sales declined 7.65% to Rs 75.46 crore in the year ended March 2026 as against Rs 81.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales21.0117.38 21 75.4681.71 -8
OPM %-12.3324.74 --11.462.36 -
PBDT-2.634.04 PL -10.460.56 PL
PBT-3.033.83 PL -11.53-0.14 -8136
NP-2.425.03 PL -8.85-0.23 -3748